Search

Your search keyword '"Ekanem, Emmanuel"' showing total 229 results
Start Over Author "Ekanem, Emmanuel"
229 results on '"Ekanem, Emmanuel"'

8. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

Author

Ekanem, Emmanuel, Neuzil, Petr, Reichlin, Tobias, Kautzner, Joseph, van der Voort, Pepijn, Jais, Pierre, Chierchia, Gian-Battista, Bulava, Alan, Blaauw, Yuri, Skala, Tomas, Fiala, Martin, Duytschaever, Mattias, Szeplaki, Gabor, Schmidt, Boris, Massoullie, Grégoire, Neven, Kars, Thomas, Olivier, Vijgen, Johan, Gandjbakhch, Estelle, Scherr, Daniel, Johannessen, Arne, Keane, David, Boveda, Serge, Maury, Philippe, García-Bolao, Ignacio, Anic, Ante, Hansen, Peter Steen, Raczka, Franck, Lepillier, Antoine, Guyomar, Yves, Gupta, Dhiraj, Van Opstal, Jurren, Defaye, Pascal, Sticherling, Christian, Sommer, Philipp, Kucera, Pavel, Osca, Joaquin, Tabrizi, Fariborz, Roux, Antoine, Gramlich, Michael, Bianchi, Stefano, Adragão, Pedro, Solimene, Francesco, Tondo, Claudio, Russo, Antonio Dello, Schreieck, Jürgen, Luik, Armin, Rana, Obaida, Frommeyer, Gerrit, Anselme, Frédéric, Kreis, Ingo, Rosso, Raphael, Metzner, Andreas, Geller, Laszlo, Baldinger, Samuel H., Ferrero, Angel, Willems, Stephan, Goette, Andreas, Mellor, Greg, Mathew, Shibu, Szumowski, Lukasz, Tilz, Roland, Iacopino, Saverio, Jacobsen, Peter Karl, George, Andrikopoulos, Osmancik, Pavel, Spitzer, Stefan, Balasubramaniam, Richard, Parwani, Abdul Shokor, Deneke, Thomas, Glowniak, Andrzej, Rossillo, Antonio, Pürerfellner, Helmut, Duncker, David, Reil, Peter, Arentz, Thomas, Steven, Daniel, Olalla, Juan José, de Jong, Jonas S. S. G., Wakili, Reza, Abbey, Selim, Timo, Gottschling, Asso, Antonio, Wong, Tom, Pierre, Bertrand, Ewertsen, Niels Christian, Bergau, Leonard, Lozano-Granero, Cristina, Rivero, Maximo, Breitenstein, Alexander, Inkovaara, Jaakko, Fareh, Samir, Latcu, Decebal Gabriel, Linz, Dominik, Müller, Patrick, Ramos-Maqueda, Javier, Beiert, Thomas, Themistoclakis, Sakis, Meininghaus, Dirk Grosse, Stix, Günter, Tzeis, Stylianos, Baran, Jakub, Almroth, Henrik, Munoz, Daniel Rodriguez, de Sousa, João, Efremidis, Michalis, Balsam, Pawel, Petru, Jan, Küffer, Thomas, Peichl, Petr, Dekker, Lukas, Della Rocca, Domenico G., Moravec, Ondrej, Funasako, Moritoshi, Knecht, Sebastien, Jauvert, Gael, Chun, Julian, Eschalier, Romain, Füting, Anna, Zhao, Alexandre, Koopman, Pieter, Laredo, Mikael, Manninger, Martin, Hansen, Jim, O’Hare, Daniel, Rollin, Anne, Jurisic, Zrinka, Fink, Thomas, Chaumont, Corentin, Rillig, Andreas, Gunawerdene, Melanie, Martin, Claire, Kirstein, Bettina, Nentwich, Karin, Lehrmann, Heiko, Sultan, Arian, Bohnen, Jan, Turagam, Mohit K., and Reddy, Vivek Y.

Abstract

Pulsed field ablation (PFA) is an emerging technology for the treatment of atrial fibrillation (AF), for which pre-clinical and early-stage clinical data are suggestive of some degree of preferentiality to myocardial tissue ablation without damage to adjacent structures. Here in the MANIFEST-17K study we assessed the safety of PFA by studying the post-approval use of this treatment modality. Of the 116 centers performing post-approval PFA with a pentaspline catheter, data were received from 106 centers (91.4% participation) regarding 17,642 patients undergoing PFA (mean age 64, 34.7% female, 57.8% paroxysmal AF and 35.2% persistent AF). No esophageal complications, pulmonary vein stenosis or persistent phrenic palsy was reported (transient palsy was reported in 0.06% of patients; 11 of 17,642). Major complications, reported for ~1% of patients (173 of 17,642), were pericardial tamponade (0.36%; 63 of 17,642) and vascular events (0.30%; 53 of 17,642). Stroke was rare (0.12%; 22 of 17,642) and death was even rarer (0.03%; 5 of 17,642). Unexpected complications of PFA were coronary arterial spasm in 0.14% of patients (25 of 17,642) and hemolysis-related acute renal failure necessitating hemodialysis in 0.03% of patients (5 of 17,642). Taken together, these data indicate that PFA demonstrates a favorable safety profile by avoiding much of the collateral damage seen with conventional thermal ablation. PFA has the potential to be transformative for the management of patients with AF.

Published
2024
Full Text
View/download PDF

12. Non-accidental broom sticks injury as a cause of post-neonatal tetanus

Author

Eyong Komomo, Torty Chimaeze, Ekanem Emmanuel, and Asindi Asindi

Subjects
tetanus, broom stick injury, nigeria, Medicine
Abstract

Introduction: non accidental injury sustained following deliberate self-harm or inflicted by parents or caregivers for disciplinary, traditional and therapeutic measures have grave consequences including exposing the incompletely child to post neonatal tetanus. This contributes to the continuing high incidence of post neonatal tetanus in developing countries.

Published
2019
Full Text
View/download PDF

13. PO-04-073 ELECTRON MICROSCOPIC INSIGHTS FROM AN ACUTE PULSED FIELD MYOCARDIAL LESION

Author

Kawamura, Iwanari, primary, Wang, Bingyan, additional, Chaudhry, Hina W., additional, Ekanem, Emmanuel, additional, Lampert, Joshua, additional, Maan, Abhishek, additional, Musikantow, Daniel R., additional, Turagam, Mohit K., additional, Miller, Marc A., additional, Whang, William, additional, Dukkipati, Srinivas R., additional, Reddy, Vivek Y., additional, and Koruth, Jacob S., additional

Published
2023
Full Text
View/download PDF

14. PO-05-239 A TARGETED APPROACH TO CARDIONEUROABLATION

Author

Ekanem, Emmanuel, primary, Turagam, Mohit, additional, Lampert, Joshua, additional, Zhang, Chi, additional, Malyshev, Yury, additional, Ambesh, Paurush, additional, Jia, Kelly, additional, Maan, Abhishek, additional, Musikantow, Daniel, additional, Miller, Marc A., additional, Koruth, Jacob S., additional, Whang, William, additional, Dukkipati, Srinivas R., additional, and Reddy, Vivek Y., additional

Published
2023
Full Text
View/download PDF

16. PO-04-096 CREATING DEEP VENTRICULAR LESIONS WITH NANOSECOND PULSED FIELD ABLATION: PATHOLOGICAL AND IMAGING INSIGHTS FROM PRECLINICAL EVALUATION

Author

Kawamura, Iwanari, primary, Reddy, Vivek Y., additional, Malyshev, Yury, additional, Jia, Kelly, additional, Ekanem, Emmanuel, additional, Lampert, Joshua, additional, Maan, Abhishek, additional, Musikantow, Daniel R., additional, Turagam, Mohit K., additional, Miller, Marc A., additional, Whang, William, additional, Dukkipati, Srinivas R., additional, and Koruth, Jacob S., additional

Published
2023
Full Text
View/download PDF

17. PO-03-189 THROMBOEMBOLISM BEFORE VS AFTER PERCUTANEOUS CLOSURE OF PERI-DEVICE LEAKS RESULTING FROM PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION

Author

Della Rocca, Domenico G., primary, Horton, Rodney P., additional, Magnocavallo, Michele, additional, King, Nicholas, additional, Turagam, Mohit, additional, Piayda, Kerstin, additional, Kramer, Anders Dahl, additional, Killu, Ammar M., additional, Galea, Roberto, additional, Jackson, Gregory, additional, Kawamura, Iwanari, additional, Kanagasundram, Arvindh N., additional, Ekanem, Emmanuel, additional, Bertog, Stefan, additional, Chierchia, Gian Battista, additional, de Asmundis, Carlo, additional, Korsholm, Kasper, additional, Sievert, Kolja, additional, Gianni, Carola, additional, Simard, Trevor, additional, Räber, Lorenz, additional, Alkhouli, Mohamad A., additional, Holmes, David R., additional, Nielsen-Kudsk, Jens Erik, additional, Sievert, Horst, additional, Reddy, Vivek Y., additional, Ellis, Christopher R., additional, and Natale, Andrea, additional

Published
2023
Full Text
View/download PDF

19. PO-04-172 OUTCOMES OF SCAR-RELATED VENTRICULAR TACHYCARDIA ABLATION WITH PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICE SUPPORT: A PROPENSITY SCORE-MATCHED ANALYSIS

Author

Kawamura, Iwanari, primary, Jia, Kelly, additional, Lampert, Joshua, additional, Malyshev, Yury, additional, Zhang, Chi, additional, Ambesh, Paurush, additional, Ekanem, Emmanuel, additional, Maan, Abhishek, additional, Musikantow, Daniel, additional, Turagam, Mohit, additional, Miller, Marc A., additional, Whang, William, additional, Koruth, Jacob S., additional, Reddy, Vivek Y., additional, and Dukkipati, Srinivas R., additional

Published
2023
Full Text
View/download PDF

20. PO-05-034 CLINICAL CHARACTERISTICS AND OUTCOMES AFTER VENTRICULAR TACHYCARDIA ABLATION USING ULTRALOW TEMPERATURE CRYOABLATION IN PATIENTS WITH PRIOR CATHETER ABLATION

Author

Maan, Abhishek, primary, Pugliese, Daniel N., additional, Musikantow, Daniel R., additional, Patel, Richa, additional, Needelman, Brandon, additional, Kawamura, Iwanari, additional, Miller, Marc A., additional, Lampert, Joshua, additional, Ekanem, Emmanuel, additional, Turagam, Mohit K., additional, Koruth, Jacob S., additional, Whang, William, additional, Dukkipati, Srinivas R., additional, and Reddy, Vivek Y., additional

Published
2023
Full Text
View/download PDF

25. Viral Hepatitis B and C infections in adolescents born preand post-Hepatitis B vaccine introduction in Calabar, Nigeria.

Author

Ikobah, Joanah M., Ada, Mbang, Uhegbu, Kelechi, Sunday, Evaristus, Otu, Vivien, Okoi-Obuli, Jacintha, and Ekanem, Emmanuel

Subjects
HEPATITIS associated antigen, YOUNG adults, HEPATITIS B vaccines, VIRAL hepatitis, HEPATITIS B
Abstract

Hepatitis B and C Virus (HBV, HCV) infections are major contributors to the burden of chronic liver diseases globally. In 2004, the Nigerian Government introduced the HBV vaccine into the National Program on Immunization (NPI) to curb the HBV infection. This study aimed to determine the prevalence and associated factors of HBV and HCV infections among adolescents in secondary schools in Calabar, Cross River State, South-South Nigeria, in the pre- and post-vaccination era. This was a school-based, cross-sectional study. Six hundred and sixty secondary school adolescents aged 10-20 years were recruited using a multistage sampling technique. Hepatitis B Surface Antigen (HBsAg) and HCV antibody screening were done respectively on the study participants using the rapid chromatographic immunoassay method. The relationship between sociodemographic variables and Hepatitis B infection was described. A p-value of less than 0.05 was considered significant. The mean age of the participants was 14.85±2.11 years. Six participants were positive for HBsAg, giving an overall prevalence of 0.9%. The positive adolescents were from public schools, and the age group mostly positive was 16 years and above (2.1%). None of the screened adolescents was positive for HCV antibody. Though the prevalence of HBV infection was low, most of those who tested positive were delivered before the introduction of the HBV vaccine into the NPI schedule. Modalities to vaccinate young people delivered before the introduction of the Hepatitis B vaccine into the NPI schedule should be developed. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

28. Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)

Author

Ekanem, Emmanuel, Reddy, Vivek Y, Schmidt, Boris, Reichlin, Tobias, Neven, Kars, Metzner, Andreas, Hansen, Jim, Blaauw, Yuri, Maury, Philippe, Arentz, Thomas, Sommer, Philipp, Anic, Ante, Anselme, Frederic, Boveda, Serge, Deneke, Tom, Willems, Stephan, van der Voort, Pepijn, Tilz, Roland, Funasako, Moritoshi, Scherr, Daniel, Wakili, Reza, Steven, Daniel, Kautzner, Josef, Vijgen, Johan, Jais, Pierre, Petru, Jan, Chun, Julian, Roten, Laurent, Füting, Anna, Rillig, Andreas, Mulder, Bart A, Johannessen, Arne, Rollin, Anne, Lehrmann, Heiko, Sohns, Christian, Jurisic, Zrinka, Savoure, Arnaud, Combes, Stephanes, Nentwich, Karin, Gunawardene, Melanie, Ouss, Alexandre, Kirstein, Bettina, Manninger, Martin, Bohnen, Jan Eric, Sultan, Arian, Peichl, Petr, Koopman, Pieter, Derval, Nicolas, Turagam, Mohit K, Neuzil, Petr, MANIFEST-PF Cooperative, Clinical sciences, Ekanem, Emmanuel/0000-0002-4128-8800, Jurisic, Zrinka, Nentwich, Karin, Ekanem, Emmanuel, Peichl, Petr, Sultan, Arian, Neuzil, Petr, Chun, Julian, Reddy, Vivek Y., Schmidt , Boris, Rillig, Andreas, Kautzner, Josef, Bohnen, Jan-Eric, Willems , Stephan, Mulder, Bart A., Arentz, Thomas, Tilz, Roland, Deneke, Tom, Manninger, Martin, VIJGEN, Johan, Roten, Laurent, Steven, Daniel, Blaauw, Yuri, Petru, Jan, Combes, Stephanes, Hansen , Jim, Funasako, Moritoshi, Jais, Pierre, Rollin, Anne, Fueting, Anna, van der Voort, Pepijn, Derval, Nicolas, Lehrmann, Heiko, Ouss, Alexandre, Savoure, Arnaud, Anselme, Frederic, Wakili, Reza, Turagam, Mohit K., Sommer, Philipp, Anic, Ante, Kirstein, Bettina, KOOPMAN, Pieter, Johannessen, Arne, Boveda, Serge, Gunawardene, Melanie, NEVEN, Kars, Metzner, Andreas, Maury, Philippe, Scherr, Daniel, Reichlin, Tobias, and Sohns, Christian

Subjects
Adult, Aged, 80 and over, Pulsed field ablation, Medizin, 610 Medicine & health, Atrial fibrillation, Catheter ablation, Survey, Middle Aged, Stroke, Young Adult, Treatment Outcome, Pulmonary Veins, Physiology (medical), Atrial Fibrillation, Catheter Ablation, Humans, Female, survey, Cardiology and Cardiovascular Medicine, Aged, Retrospective Studies
Abstract

Aims Pulsed field ablation (PFA) is a novel atrial fibrillation (AF) ablation modality that has demonstrated preferential tissue ablation, including no oesophageal damage, in first-in-human clinical trials. In the MANIFEST-PF survey, we investigated the 'real world' performance of the only approved PFA catheter, including acute effectiveness and safety-in particular, rare oesophageal effects and other unforeseen PFA-related complications. Methods and results This retrospective survey included all 24 clinical centres using the pentaspline PFA catheter after regulatory approval. Institution-level data were obtained on patient characteristics, procedure parameters, acute efficacy, and adverse events. With an average of 73 patients treated per centre (range 7-291), full cohort included 1758 patients: mean age 61.6 years (range 19-92), female 34%, first-time ablation 94%, paroxysmal/persistent AF 58/35%. Most procedures employed deep sedation without intubation (82.1%), and 15.1% were discharged same day. Pulmonary vein isolation (PVI) was successful in 99.9% (range 98.9-100%). Procedure time was 65 min (38-215). There were no oesophageal complications or phrenic nerve injuries persisting past hospital discharge. Major complications (1.6%) were pericardial tamponade (0.97%) and stroke (0.4%); one stroke resulted in death (0.06%). Minor complications (3.9%) were primarily vascular (3.3%), but also included transient phrenic nerve paresis (0.46%), and TIA (0.11%). Rare complications included coronary artery spasm, haemoptysis, and dry cough persistent for 6 weeks (0.06% each). Conclusion In a large cohort of unselected patients, PFA was efficacious for PVI, and expressed a safety profile consistent with preferential tissue ablation. However, the frequency of 'generic' catheter complications (tamponade, stroke) underscores the need for improvement. There was no specific funding received to conduct this survey. Conflict of interest: V.Y.R. reports receiving consulting fees and equity (stock) from Farapulse Inc. and is a consultant for Boston Scientific Inc.; he also has additional disclosures unrelated to this manuscript that are listed in the Supplementary material online. B.S. reports receiving speaker’s fees and research grants from Boston Scientific/Farapulse, Medtronic, Biosense Webster, and Abbott. T.R. reports research grants from the Swiss National Science Foundation, the Swiss Heart Foundation, and the sitem insel support fund. Speaker/consulting honoraria or travel support from Abbott/SJM, Bayer, Biosense Webster, Biotronik, Boston Scientific, Daiichi Sankyo, Medtronic, and Pfizer-BMS. Support for his institution’s fellowship programme from Abbott/SJM, Biosense Webster, Biotronik, Boston Scientific, and Medtronic. L.R. reports receiving speaker honoraria from Abbott/SJM and consulting honoraria from Medtronic. K.N. reports speaker’s Fees from Farapulse, Inc. A.M. reports research grant and fees from Farapulse. A.R. reports receiving research grant from Farapulse. J.H. reports receiving speaker fees and grant support from Biosense Webster and Medtronic. Y.B.: reports receiving Research grant from Medtronic and Atricure and consulting fees from Abbott, Biosense Webster, Boston Scientific. P.S. reports member of the advisory board for Abbott, Biosense Webster, Boston Scientific, and Medtronic. C.S. reports receiving modest honoraria from Medtronic. A.A. reports receiving consultant fees from Farapulse Inc., Boston Scientific Inc., Galaxy Medical Inc., Biosense Webster, and performs contracted research for Farapulse Inc., Boston Scientific Inc., Galaxy Medical Inc., Biosense Webster. F.A. reports receiving consulting fees from Boston Scientific, Medtronic and Microport CRM. S.B. reports receiving consulting fees for Medtronic, Boston Scientific, Microport, Zoll, and BMS. T.D. reports receiving speaker honoraria from Galaxy Medical, Abbott and Biotronik, being a consultant to Farapulse, and serving on a Clinical Events Committee for Boston Scientific. S.W. reports receiving grants and personal fees from Abbott, Boston Scientific, Medtronic, and personal fees from Boehringer Ingelheim, Brystol Myers Squibb, Bayer Vital, Accutus, Daiichi, Farapulse Inc. M.G. reports grant from Farapulse Inc. and Abbott. R.T. reports receiving consulting fees from Boston Scientific, Abbot Medical, Biotronik, and speakers honorarium from Boston Scientific, Abbot Medical, Biotronik, Biosense Webster. B.K. reports receiving Travel and Congress Sponsoring from Biotronik, Abbott, Impulse Dynamics, DGK AG EP, EHRA, Pfizer; she also received fellowship sponsoring from Johnson & Johnson, Boston Scientific and Lecture Honorary from Biotronik, Impulse Dynamics, C.T.I. GmbH, Doctrina Med. D.S. reports receiving an educational grant from Farapulse Inc., and is a consultant For Boston Scientific Inc. R.W. reports receiving consultant fees and travel expenses from Boston Scientific and Biotronik; investigator-initiated funding for research projects (initiated by him) from Bristol-Myers Squibb, Pfizer, and Boston Scientific; and speaking honoraria from Boston Scientific, Biotronik, and Medtronic. D.S. reports receiving speaking fees from Pfizer, Bayer, Abbott, Johnson & Johnson, and Medtronic; grant from Abbott, Johnson & Johnson, and Boston Scientific; and consulting fees from Boston Scientific and Johnson & Johnson. A.S. reports receiving lecture and consulting honoraria from Medtronic, Abbott, and Bayer. J.K. reports personal fees from Bayer, Biosense Webster, Boehringer Ingelheim, Medtronic, and Abbott for participation in scientific advisory boards, and has received speaker honoraria from Bayer, Biosense Webster, Biotronik, Boehringer Ingelheim, CathVision, Medtronic, Mylan, Pfizer, ProMed, and Abbott. P.J. reports receiving equity from Farapulse and consulting fees and grant from Boston Scientific. N.D. reports receiving consulting fees from Boston scientific. J.C. reports receiving speaker’s fees and research grants from Boston Scientific/Farapulse, Medtronic, Biosense Webster, and Abbott. P.N. reports receiving grant from the Ministry of Health, Czech Republic, DRO (NHH, 00023884). All the remaining authors have declared no conflict of interest.

Published
2022

30. PO-676-02 RISK OF VENTRICULAR ACTIVATION CULMINATING IN SUSTAINED VENTRICULAR ARRHYTHMIAS DURING PULSED FIELD ABLATION: PRECLINICAL INSIGHTS FROM ABLATION IN HEALTHY OR POST-MYOCARDIAL INFARCT MODELS

Author

Kawamura, Iwanari, primary, Reddy, Vivek Y., additional, Wang, Bingyan, additional, Santos-Gallego, Carlos, additional, Buck, Eric D., additional, Kingston, Amanda, additional, Garrity, Jason M., additional, Brose, Richard, additional, Ekanem, Emmanuel, additional, Musikantow, Daniel Ross, additional, Turagam, Mohit K., additional, Whang, William, additional, Miller, Marc A., additional, Dukkipati, Srinivas R., additional, and Koruth, Jacob S., additional

Published
2022
Full Text
View/download PDF

31. PO-700-01 IMPACT OF VACCINATION STATUS ON QRS AMPLITUDE DIMINUTION IN PATIENTS HOSPITALIZED WITH COVID-19

Author

Lampert, Joshua, primary, Havaldar, Shreyas, additional, Miller, Marc A., additional, Koruth, Jacob S., additional, Whang, William, additional, Maan, Abhishek, additional, Zhang, Chi, additional, Sljapic, Tatjana N., additional, Ekanem, Emmanuel, additional, Turagam, Mohit K., additional, Langan, Marie-Noelle S., additional, Musikantow, Daniel, additional, Musikantow, Daniel Ross, additional, Dukkipati, Srinivas R., additional, Glicksberg, Benjamin, additional, and Reddy, Vivek Y., additional

Published
2022
Full Text
View/download PDF

32. PO-619-07 CHEST WALL ADIPOSE TISSUE EXCISIONAL BIOPSY DURING PACEMAKER OR DEFIBRILLATOR IMPLANTATION: FIRST REPORT OF A NEW TECHNIQUE TO DIAGNOSE AND SUBTYPE AMYLOIDOSIS

Author

Zhang, Chi, primary, Musikantow, Daniel Ross, additional, Pugliese, Daniel N., additional, Ekanem, Emmanuel, additional, Mitter, Sumeet, additional, Moss, Noah, additional, Mancini, Donna, additional, Gandhi, Jonathan, additional, Maan, Abhishek, additional, Sljapic, Tatjana N., additional, Lampert, Joshua, additional, Whang, William, additional, Koruth, Jacob S., additional, Langan, Marie-Noelle S., additional, Turagam, Mohit K., additional, Dukkipati, Srinivas R., additional, Miller, Marc A., additional, and Reddy, Vivek Y., additional

Published
2022
Full Text
View/download PDF

33. PO-700-02 FEASIBILITY AND SAFETY OF INTRACARDIAC ECHOCARDIOGRAPHY-GUIDED IMPLANTATION OF THE WATCHMAN-FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITHOUT PRE-PROCEDURAL IMAGING: A MULTI-NATIONAL REGISTRY

Author

Ekanem, Emmanuel, primary, Turagam, Mohit, additional, Neuzil, Petr, additional, Doshi, Shephal K., additional, Valderrabano, Miguel, additional, Hala, Pavel, additional, Tang, Stephen, additional, Musikantow, Daniel, additional, Lampert, Joshua, additional, Maan, Abhishek, additional, Pugliese, Daniel N., additional, Gandhi, Jonathan, additional, Miller, Marc A., additional, Koruth, Jacob S., additional, Whang, William, additional, Langan, Marie-Noelle S., additional, Dukkipati, Srinivas R., additional, and Reddy, Vivek Y., additional

Published
2022
Full Text
View/download PDF

34. CE-543-04 INTER-ATRIAL BLOCK IDENTIFIES PATIENTS WITH LOW CHA2DS2-VASC SCORE BUT HIGH STROKE RISK

Author

Lampert, Joshua, primary, Havaldar, Shreyas, additional, Power, David, additional, Miller, Marc A., additional, Maan, Abhishek, additional, Menon, Kartikeya, additional, Ekanem, Emmanuel, additional, Gandhi, Jonathan, additional, Pugliese, Daniel N., additional, Musikantow, Daniel Ross, additional, Turagam, Mohit K., additional, Fuster, Valentin, additional, Dukkipati, Srinivas R., additional, Glicksberg, Benjamin, additional, and Reddy, Vivek Y., additional

Published
2022
Full Text
View/download PDF

35. PO-684-06 ARRHYTHMIC MITRAL VALVE PROLAPSE WITH ONLY MILD OR MODERATE MITRAL REGURGITATION: CHARACTERIZATION BY PET/MRI

Author

Arbiol, Ana Devesa, primary, Patel, Sonika, additional, Miller, Marc A., additional, Liao, Steve, additional, Robson, Philip, additional, Pyzik, Renata, additional, Jacobi, Adam, additional, Adams, David H., additional, El-Eshmawi, Ahmed, additional, Boateng, Percy, additional, Pandis, Dimosthenis, additional, Pugliese, Daniel N., additional, Gandhi, Jonathan, additional, Ekanem, Emmanuel, additional, Musikantow, Daniel Ross, additional, Koruth, Jacob S., additional, Wang, William, additional, Turagam, Mohit, additional, Dukkipati, Srinivas R., additional, Reddy, Vivek Y., additional, and Fayad, Zahi, additional

Published
2022
Full Text
View/download PDF

36. PO-666-04 HYPOXIC RESPIRATORY FAILURE DUE TO IATROGENIC ATRIAL SEPTAL DEFECT AFTER RADIOFREQUENCY ABLATION REQUIRING PERCUTANEOUS CLOSURE

Author

Ekanem, Emmanuel, primary, Turagam, Mohit, additional, Musikantow, Daniel, additional, Lampert, Joshua, additional, Maan, Abhishek, additional, Pugliese, Daniel N., additional, Gandhi, Jonathan, additional, Miller, Marc A., additional, Koruth, Jacob S., additional, Whang, William, additional, Syros, Georgios, additional, Langan, Marie-Noelle S., additional, Dukkipati, Srinivas R., additional, Reddy, Vivek Y., additional, and Sljapic, Tatjana N., additional

Published
2022
Full Text
View/download PDF

37. PO-681-02 FEASIBILITY OF FLUOROLESS PERSISTENT ATRIAL FIBRILLATION ABLATION USING A FOCAL LATTICE-TIP CATHETER THAT TOGGLES BETWEEN PULSE FIELD AND RADIOFREQUENCY ENERGY

Author

Ekanem, Emmanuel, primary, Neuzil, Petr, additional, Turagam, Mohit, additional, Petru, Jan, additional, Funasako, Moritoshi, additional, Kralovec, Stepan, additional, Musikantow, Daniel, additional, Maan, Abhishek, additional, Lampert, Joshua, additional, Pugliese, Daniel N., additional, Gandhi, Jonathan, additional, Sljapic, Tatjana N., additional, Miller, Marc A., additional, Whang, William, additional, Koruth, Jacob S., additional, Syros, Georgios, additional, Dukkipati, Srinivas R., additional, and Reddy, Vivek Y., additional

Published
2022
Full Text
View/download PDF

38. CE-541-03 OCCURRENCE OF ATRIAL FIBRILLATION AFTER RECEIVING A SARS- COV-2 VACCINE: REPORT FROM CENTERS FOR DISEASE CONTROL AND PREVENTION VAERS DATABASE

Author

Maan, Abhishek, primary, Musikantow, Daniel, additional, Needelman, Brandon S., additional, Lampert, Joshua, additional, Ekanem, Emmanuel, additional, Gandhi, Jonathan, additional, Turagam, Mohit K., additional, Whang, William, additional, Dukkipati, Srinivas R., additional, and Reddy, Vivek Y., additional

Published
2022
Full Text
View/download PDF

40. PO-06-171 A CORONARY SPASM SUB-STUDY OF MANIFEST-17K

Author

Ekanem, Emmanuel, Chierchia, Gian B., BOVEDA, SERGE, Bulava, Alan, Kautzner, Josef, Petru, Jan, Dekker, Lukas, Neuzil, Petr, Duytschaever, Mattias F., Schmidt, Boris, MASSOULLIE, Grégoire, Solimene, Francesco, Andrikopoulos, Georgios, Fiala, Martin, Della Rocca, Domenico, Peichl, Petr, Van Der Voort, Pepijn H., Knecht, Sebastien, Eschalier, Romain, Funasako, Moritoshi, Turagam, Mohit K., and Reddy, Vivek Y.

Published
2024
Full Text
View/download PDF

41. Abstract 10637: A Pooled Multi-National Validation Study of a Machine Learning, High-Sensitivity Troponin-Based Multi-Proteomic Model to Predict the Presence of Obstructive Coronary Artery Disease as Compared to High Sensitivity Troponin Alone in a Subset of Patients with Diabetes

Author

Gattani, Raghav, primary, Ekanem, Emmanuel, additional, Ofosu-Somuah, Araba, additional, Neumann, Johannes T, additional, McCarthy, Cian, additional, Shah, Palak, additional, Magaret, Craig, additional, Rhyne, Rhonda F, additional, Barnes, Grady, additional, Peters, Celine, additional, Westermann, Dirk, additional, Defilippi, Christopher, additional, and Januzzi, James L, additional

Published
2021
Full Text
View/download PDF

45. COMPLICATED VENTRICULAR SEPTAL RUPTURE REQUIRING MECHANICAL CIRCULATORY SUPPORT BRIDGE TO HEART TRANSPLANT: A CONSEQUENCE OF LATE PRESENTING MYOCARDIAL INFARCTION IN THE ERA OF COVID-19

Author

Gattani, Raghav, primary, Bakhshi, Hooman, additional, Ekanem, Emmanuel, additional, Desai, Mehul, additional, Sinha, Shashank, additional, Speir, Alan, additional, Singh, Ramesh, additional, Sherwood, Matthew, additional, Tehrani, Behnam, additional, and Batchelor, Wayne, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results